2024 ACC/AHA/AACVPR/APMA/ABC/SCAI/SVM/SVN/SVS/SIR/VESS Guideline for the Management of Lower Extremity Peripheral Artery Disease

The “2024 ACC/AHA/AACVPR/APMA/ABC/SCAI/SVM/SVN/SVS/SIR/VESS Guideline for the Management of Lower Extremity Peripheral Artery Disease” provides recommendations to guide clinicians in the treatment of patients with lower extremity peripheral artery disease across its multiple clinical presentation su...

Full description

Saved in:
Bibliographic Details
Published inJournal of the American College of Cardiology Vol. 83; no. 24; pp. 2497 - 2604
Main Authors Gornik, Heather L., Aronow, Herbert D., Goodney, Philip P., Arya, Shipra, Brewster, Luke Packard, Byrd, Lori, Chandra, Venita, Drachman, Douglas E., Eaves, Jennifer M., Ehrman, Jonathan K., Evans, John N., Getchius, Thomas S.D., Gutiérrez, J. Antonio, Hawkins, Beau M., Hess, Connie N., Ho, Karen J., Jones, W. Schuyler, Kim, Esther S.H., Kinlay, Scott, Kirksey, Lee, Kohlman-Trigoboff, Debra, Long, Chandler A., Pollak, Amy West, Sabri, Saher S., Sadwin, Lawrence B., Secemsky, Eric A., Serhal, Maya, Shishehbor, Mehdi H., Treat-Jacobson, Diane, Wilkins, Luke R.
Format Journal Article
LanguageEnglish
Published Elsevier Inc 18.06.2024
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The “2024 ACC/AHA/AACVPR/APMA/ABC/SCAI/SVM/SVN/SVS/SIR/VESS Guideline for the Management of Lower Extremity Peripheral Artery Disease” provides recommendations to guide clinicians in the treatment of patients with lower extremity peripheral artery disease across its multiple clinical presentation subsets (ie, asymptomatic, chronic symptomatic, chronic limb-threatening ischemia, and acute limb ischemia). A comprehensive literature search was conducted from October 2020 to June 2022, encompassing studies, reviews, and other evidence conducted on human subjects that was published in English from PubMed, EMBASE, the Cochrane Library, CINHL Complete, and other selected databases relevant to this guideline. Additional relevant studies, published through May 2023 during the peer review process, were also considered by the writing committee and added to the evidence tables where appropriate. Recommendations from the “2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease” have been updated with new evidence to guide clinicians. In addition, new recommendations addressing comprehensive care for patients with peripheral artery disease have been developed.
ISSN:0735-1097
DOI:10.1016/j.jacc.2024.02.013